Analysis
PublicGLAXOSMITHKLINE LLC holds $2.8B across 206 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 4 related awards under parent 75A50122D00002. Recompete timing centers on the May 21, 2027 PoP end — agencies typically plan 12–18 months ahead.
Contract facts
FederalNo full NAICS 541714 intel page yet. Browse NAICS intelligence
THE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY FOR ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR THE DEPARTMENT OF HEALTH AND HUMAN SERVICES UNDER IDIQ 75A50122D000002 DURING BASE PERIOD YR. 3. PERIOD OF PERFORMANCE: FEBRUARY
Recompete timing
PublicCurrent PoP ends May 21, 2027 (277 days remaining). Agencies typically plan 12–18 months ahead — at 9.1 months out, that window is already open. The buying decision is likely already in motion.
Watch this contract — one email →Incumbent footprint
Public recordGLAXOSMITHKLINE LLC — $2.8B obligated across 206 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Track this contract
Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open GLAXOSMITHKLINE LLC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Frequently asked questions
What is contract 75A50124F61010?
75A50124F61010 (THE PURPOSE OF THIS TASK ORDER IS TO PROCURE STORAGE AND STABILITY FOR ANTIGENS AND ADJUVANTS FROM PRIOR CONTRACTS FOR…) is a Department of Health and Human Services (HHS) award with an estimated value of $40.9M, currently held by GLAXOSMITHKLINE LLC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.
Who is the incumbent on 75A50124F61010?
GLAXOSMITHKLINE LLC is the incumbent with $2.8B across 206 related awards in SCOUT’s public footprint. The current period of performance ends May 21, 2027.
When does 75A50124F61010 come up for recompete?
SCOUT tracks a period-of-performance end of May 21, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →